Eosinophilic Granulomatosis Treatment
Eosinophilic Granulomatosis is a rare autoimmune disease usually characterized by acute asthma, v ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Lung Cancer 1.2.3 Breast Cancer 1.2.4 Colorectal Cancer 1.2.5 Leukemia 1.2.6 Prostate Cancer 1.2.7 Cervical Cancer 1.2.8 Glioblastoma 1.2.9 Others 1.3 Market by Application 1.3.1 Global Personalized Cancer Vaccines Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Homecare 1.3.4 Specialty Clinics 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Personalized Cancer Vaccines Market Perspective (2016-2027) 2.2 Personalized Cancer Vaccines Growth Trends by Regions 2.2.1 Personalized Cancer Vaccines Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Personalized Cancer Vaccines Historic Market Share by Regions (2016-2021) 2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027) 2.3 Personalized Cancer Vaccines Industry Dynamic 2.3.1 Personalized Cancer Vaccines Market Trends 2.3.2 Personalized Cancer Vaccines Market Drivers 2.3.3 Personalized Cancer Vaccines Market Challenges 2.3.4 Personalized Cancer Vaccines Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Personalized Cancer Vaccines Players by Revenue 3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2016-2021) 3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2016-2021) 3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue 3.4 Global Personalized Cancer Vaccines Market Concentration Ratio 3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2020 3.5 Personalized Cancer Vaccines Key Players Head office and Area Served 3.6 Key Players Personalized Cancer Vaccines Product Solution and Service 3.7 Date of Enter into Personalized Cancer Vaccines Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Personalized Cancer Vaccines Breakdown Data by Type 4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2016-2021) 4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027) 5 Personalized Cancer Vaccines Breakdown Data by Application 5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2016-2021) 5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Personalized Cancer Vaccines Market Size (2016-2027) 6.2 North America Personalized Cancer Vaccines Market Size by Type 6.2.1 North America Personalized Cancer Vaccines Market Size by Type (2016-2021) 6.2.2 North America Personalized Cancer Vaccines Market Size by Type (2022-2027) 6.2.3 North America Personalized Cancer Vaccines Market Size by Type (2016-2027) 6.3 North America Personalized Cancer Vaccines Market Size by Application 6.3.1 North America Personalized Cancer Vaccines Market Size by Application (2016-2021) 6.3.2 North America Personalized Cancer Vaccines Market Size by Application (2022-2027) 6.3.3 North America Personalized Cancer Vaccines Market Size by Application (2016-2027) 6.4 North America Personalized Cancer Vaccines Market Size by Country 6.4.1 North America Personalized Cancer Vaccines Market Size by Country (2016-2021) 6.4.2 North America Personalized Cancer Vaccines Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Personalized Cancer Vaccines Market Size (2016-2027) 7.2 Europe Personalized Cancer Vaccines Market Size by Type 7.2.1 Europe Personalized Cancer Vaccines Market Size by Type (2016-2021) 7.2.2 Europe Personalized Cancer Vaccines Market Size by Type (2022-2027) 7.2.3 Europe Personalized Cancer Vaccines Market Size by Type (2016-2027) 7.3 Europe Personalized Cancer Vaccines Market Size by Application 7.3.1 Europe Personalized Cancer Vaccines Market Size by Application (2016-2021) 7.3.2 Europe Personalized Cancer Vaccines Market Size by Application (2022-2027) 7.3.3 Europe Personalized Cancer Vaccines Market Size by Application (2016-2027) 7.4 Europe Personalized Cancer Vaccines Market Size by Country 7.4.1 Europe Personalized Cancer Vaccines Market Size by Country (2016-2021) 7.4.2 Europe Personalized Cancer Vaccines Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2016-2027) 8.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type 8.2.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2027) 8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application 8.3.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2027) 8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region 8.4.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Personalized Cancer Vaccines Market Size (2016-2027) 9.2 Latin America Personalized Cancer Vaccines Market Size by Type 9.2.1 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021) 9.2.2 Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027) 9.2.3 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2027) 9.3 Latin America Personalized Cancer Vaccines Market Size by Application 9.3.1 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021) 9.3.2 Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027) 9.3.3 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2027) 9.4 Latin America Personalized Cancer Vaccines Market Size by Country 9.4.1 Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021) 9.4.2 Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2016-2027) 10.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type 10.2.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2027) 10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application 10.3.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2027) 10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country 10.4.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Advaxis Inc 11.1.1 Advaxis Inc Company Details 11.1.2 Advaxis Inc Business Overview 11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction 11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.1.5 Advaxis Inc Recent Development 11.2 Personalis 11.2.1 Personalis Company Details 11.2.2 Personalis Business Overview 11.2.3 Personalis Personalized Cancer Vaccines Introduction 11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.2.5 Personalis Recent Development 11.3 Hoffmann-La Roche Ltd 11.3.1 Hoffmann-La Roche Ltd Company Details 11.3.2 Hoffmann-La Roche Ltd Business Overview 11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction 11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.3.5 Hoffmann-La Roche Ltd Recent Development 11.4 BioNtech 11.4.1 BioNtech Company Details 11.4.2 BioNtech Business Overview 11.4.3 BioNtech Personalized Cancer Vaccines Introduction 11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.4.5 BioNtech Recent Development 11.5 Celldex 11.5.1 Celldex Company Details 11.5.2 Celldex Business Overview 11.5.3 Celldex Personalized Cancer Vaccines Introduction 11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.5.5 Celldex Recent Development 11.6 CureVac AG 11.6.1 CureVac AG Company Details 11.6.2 CureVac AG Business Overview 11.6.3 CureVac AG Personalized Cancer Vaccines Introduction 11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.6.5 CureVac AG Recent Development 11.7 Genetech 11.7.1 Genetech Company Details 11.7.2 Genetech Business Overview 11.7.3 Genetech Personalized Cancer Vaccines Introduction 11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.7.5 Genetech Recent Development 11.8 Genocea 11.8.1 Genocea Company Details 11.8.2 Genocea Business Overview 11.8.3 Genocea Personalized Cancer Vaccines Introduction 11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.8.5 Genocea Recent Development 11.9 Gritstone Oncology 11.9.1 Gritstone Oncology Company Details 11.9.2 Gritstone Oncology Business Overview 11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction 11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.9.5 Gritstone Oncology Recent Development 11.10 ISA Pharmaceuticals 11.10.1 ISA Pharmaceuticals Company Details 11.10.2 ISA Pharmaceuticals Business Overview 11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction 11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.10.5 ISA Pharmaceuticals Recent Development 11.11 Merck 11.11.1 Merck Company Details 11.11.2 Merck Business Overview 11.11.3 Merck Personalized Cancer Vaccines Introduction 11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.11.5 Merck Recent Development 11.12 Moderna Therapeutics 11.12.1 Moderna Therapeutics Company Details 11.12.2 Moderna Therapeutics Business Overview 11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction 11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021) 11.12.5 Moderna Therapeutics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Personalized Cancer Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Lung Cancer Table 3. Key Players of Breast Cancer Table 4. Key Players of Colorectal Cancer Table 5. Key Players of Leukemia Table 6. Key Players of Prostate Cancer Table 7. Key Players of Cervical Cancer Table 8. Key Players of Glioblastoma Table 9. Key Players of Others Table 10. Global Personalized Cancer Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Personalized Cancer Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Personalized Cancer Vaccines Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Personalized Cancer Vaccines Market Share by Regions (2016-2021) Table 14. Global Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Personalized Cancer Vaccines Market Share by Regions (2022-2027) Table 16. Personalized Cancer Vaccines Market Trends Table 17. Personalized Cancer Vaccines Market Drivers Table 18. Personalized Cancer Vaccines Market Challenges Table 19. Personalized Cancer Vaccines Market Restraints Table 20. Global Personalized Cancer Vaccines Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Personalized Cancer Vaccines Market Share by Players (2016-2021) Table 22. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Vaccines as of 2020) Table 23. Ranking of Global Top Personalized Cancer Vaccines Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Personalized Cancer Vaccines Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Personalized Cancer Vaccines Product Solution and Service Table 27. Date of Enter into Personalized Cancer Vaccines Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million) Table 30. Global Personalized Cancer Vaccines Revenue Market Share by Type (2016-2021) Table 31. Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Personalized Cancer Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Personalized Cancer Vaccines Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Personalized Cancer Vaccines Revenue Market Share by Application (2016-2021) Table 35. Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Personalized Cancer Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million) Table 38. North America Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million) Table 40. North America Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 67. Advaxis Inc Company Details Table 68. Advaxis Inc Business Overview Table 69. Advaxis Inc Personalized Cancer Vaccines Product Table 70. Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 71. Advaxis Inc Recent Development Table 72. Personalis Company Details Table 73. Personalis Business Overview Table 74. Personalis Personalized Cancer Vaccines Product Table 75. Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 76. Personalis Recent Development Table 77. Hoffmann-La Roche Ltd Company Details Table 78. Hoffmann-La Roche Ltd Business Overview Table 79. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Table 80. Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 81. Hoffmann-La Roche Ltd Recent Development Table 82. BioNtech Company Details Table 83. BioNtech Business Overview Table 84. BioNtech Personalized Cancer Vaccines Product Table 85. BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 86. BioNtech Recent Development Table 87. Celldex Company Details Table 88. Celldex Business Overview Table 89. Celldex Personalized Cancer Vaccines Product Table 90. Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 91. Celldex Recent Development Table 92. CureVac AG Company Details Table 93. CureVac AG Business Overview Table 94. CureVac AG Personalized Cancer Vaccines Product Table 95. CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 96. CureVac AG Recent Development Table 97. Genetech Company Details Table 98. Genetech Business Overview Table 99. Genetech Personalized Cancer Vaccines Product Table 100. Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 101. Genetech Recent Development Table 102. Genocea Company Details Table 103. Genocea Business Overview Table 104. Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 105. Genocea Recent Development Table 106. Gritstone Oncology Company Details Table 107. Gritstone Oncology Business Overview Table 108. Gritstone Oncology Personalized Cancer Vaccines Product Table 109. Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 110. Gritstone Oncology Recent Development Table 111. ISA Pharmaceuticals Company Details Table 112. ISA Pharmaceuticals Business Overview Table 113. ISA Pharmaceuticals Personalized Cancer Vaccines Product Table 114. ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 115. ISA Pharmaceuticals Recent Development Table 116. Merck Company Details Table 117. Merck Business Overview Table 118. Merck Personalized Cancer Vaccines Product Table 119. Merck Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 120. Merck Recent Development Table 121. Moderna Therapeutics Company Details Table 122. Moderna Therapeutics Business Overview Table 123. Moderna Therapeutics Personalized Cancer Vaccines Product Table 124. Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021) & (US$ Million) Table 125. Moderna Therapeutics Recent Development Table 126. Research Programs/Design for This Report Table 127. Key Data Information from Secondary Sources Table 128. Key Data Information from Primary Sources List of Figures Figure 1. Global Personalized Cancer Vaccines Market Share by Type: 2020 VS 2027 Figure 2. Lung Cancer Features Figure 3. Breast Cancer Features Figure 4. Colorectal Cancer Features Figure 5. Leukemia Features Figure 6. Prostate Cancer Features Figure 7. Cervical Cancer Features Figure 8. Glioblastoma Features Figure 9. Others Features Figure 10. Global Personalized Cancer Vaccines Market Share by Application: 2020 VS 2027 Figure 11. Hospitals Case Studies Figure 12. Homecare Case Studies Figure 13. Specialty Clinics Case Studies Figure 14. Others Case Studies Figure 15. Personalized Cancer Vaccines Report Years Considered Figure 16. Global Personalized Cancer Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 17. Global Personalized Cancer Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 18. Global Personalized Cancer Vaccines Market Share by Regions: 2020 VS 2027 Figure 19. Global Personalized Cancer Vaccines Market Share by Regions (2022-2027) Figure 20. Global Personalized Cancer Vaccines Market Share by Players in 2020 Figure 21. Global Top Personalized Cancer Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalized Cancer Vaccines as of 2020 Figure 22. The Top 10 and 5 Players Market Share by Personalized Cancer Vaccines Revenue in 2020 Figure 23. Global Personalized Cancer Vaccines Revenue Market Share by Type (2016-2021) Figure 24. Global Personalized Cancer Vaccines Revenue Market Share by Type (2022-2027) Figure 25. North America Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. North America Personalized Cancer Vaccines Market Share by Type (2016-2027) Figure 27. North America Personalized Cancer Vaccines Market Share by Application (2016-2027) Figure 28. North America Personalized Cancer Vaccines Market Share by Country (2016-2027) Figure 29. United States Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Canada Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Europe Personalized Cancer Vaccines Market Share by Type (2016-2027) Figure 33. Europe Personalized Cancer Vaccines Market Share by Application (2016-2027) Figure 34. Europe Personalized Cancer Vaccines Market Share by Country (2016-2027) Figure 35. Germany Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. France Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. U.K. Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Italy Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Russia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Nordic Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Asia-Pacific Personalized Cancer Vaccines Market Share by Type (2016-2027) Figure 43. Asia-Pacific Personalized Cancer Vaccines Market Share by Application (2016-2027) Figure 44. Asia-Pacific Personalized Cancer Vaccines Market Share by Region (2016-2027) Figure 45. China Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Japan Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. South Korea Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Southeast Asia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. India Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Australia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Latin America Personalized Cancer Vaccines Market Share by Type (2016-2027) Figure 53. Latin America Personalized Cancer Vaccines Market Share by Application (2016-2027) Figure 54. Latin America Personalized Cancer Vaccines Market Share by Country (2016-2027) Figure 55. Mexico Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Brazil Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Middle East & Africa Personalized Cancer Vaccines Market Share by Type (2016-2027) Figure 59. Middle East & Africa Personalized Cancer Vaccines Market Share by Application (2016-2027) Figure 60. Middle East & Africa Personalized Cancer Vaccines Market Share by Country (2016-2027) Figure 61. Turkey Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Saudi Arabia Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. UAE Personalized Cancer Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Advaxis Inc Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 65. Personalis Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 66. Hoffmann-La Roche Ltd Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 67. BioNtech Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 68. Celldex Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 69. CureVac AG Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 70. Genetech Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 71. Genocea Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 72. Gritstone Oncology Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 73. ISA Pharmaceuticals Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 74. Merck Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 75. Moderna Therapeutics Revenue Growth Rate in Personalized Cancer Vaccines Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed
Advaxis Inc Personalis Hoffmann-La Roche Ltd BioNtech Celldex CureVac AG Genetech Genocea Gritstone Oncology ISA Pharmaceuticals Merck Moderna Therapeutics
Eosinophilic Granulomatosis is a rare autoimmune disease usually characterized by acute asthma, v ... Read More
The patient-tailored therapies for the treatment of variety of disease are known as personalized ... Read More
Dermal Allograft is a technique used to treat and improve the damaged inner layer of skin called ... Read More
Embedded Connectivity Solutions are technological services and offerings that provide real-time i ... Read More